Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
Clinical trial NCT02240238 · COMPLETED
Trial details
- NCT number
- NCT02240238
- Sponsor
- NanoCarrier Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2019-05-06
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.